LORENZA METELLUS-PHILISTIN: Open Payments
NPI 1396393492 · MIRAMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $160 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| TMS NeuroHealth Centers Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: TMS NeuroHealth Centers Inc., Auvelity, ELIQUIS, CAPLYTA, LYBALVI, INGREZZA.
Industry payments across FL — which companies pay providers there.
